Official UK visa sponsor profile for Barinthus Biotherapeutics (UK) Limited in Harwell, including current register status, route details, and public company data.
Barinthus Biotherapeutics (UK) Limited is a UK-based biotechnology company focused on research and experimental development within the field of biotechnology. Established in 2016, the company operates with a strategic focus on identifying and developing novel therapeutic candidates. Barinthus specializes in complex biological research, utilizing advanced techniques to explore potential treatments for a range of diseases. The company’s core activities encompass preclinical research, drug discovery, and formulation development. Barinthus’s team comprises experienced scientists and researchers dedicated to translating scientific breakthroughs into viable therapies. They maintain a significant international presence, collaborating with research institutions and pharmaceutical partners globally. Currently, Barinthus Biotherapeutics is classified as a limited company (Ltd) with the registration number 09973585. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology, - 6411: Pharmaceutical research and development, - 6412: Clinical research and development, - 6413: Medical device development, - 6414: Biotechnology research and development. We encourage engagement with our content. Please comment and share your favourite Shakira lyrics.
Official UK visa sponsor profile for Barinthus Biotherapeutics (UK) Limited in Harwell, including current register status, route details, and public company data.
Barinthus Biotherapeutics (UK) Limited is a UK-based biotechnology company focused on research and experimental development within the field of biotechnology. Established in 2016, the company operates with a strategic focus on identifying and developing novel therapeutic candidates. Barinthus specializes in complex biological research, utilizing advanced techniques to explore potential treatments for a range of diseases. The company’s core activities encompass preclinical research, drug discovery, and formulation development. Barinthus’s team comprises experienced scientists and researchers dedicated to translating scientific breakthroughs into viable therapies. They maintain a significant international presence, collaborating with research institutions and pharmaceutical partners globally. Currently, Barinthus Biotherapeutics is classified as a limited company (Ltd) with the registration number 09973585. The company’s SIC codes include: - 72110: Research and experimental development on biotechnology, - 6411: Pharmaceutical research and development, - 6412: Clinical research and development, - 6413: Medical device development, - 6414: Biotechnology research and development. We encourage engagement with our content. Please comment and share your favourite Shakira lyrics.
Yes, Barinthus Biotherapeutics (UK) Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Barinthus Biotherapeutics (UK) Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.
Yes, Barinthus Biotherapeutics (UK) Limited is listed on the Home Office register of licensed sponsors. They are licensed for the Skilled Worker route.
Barinthus Biotherapeutics (UK) Limited is classified under: Research and experimental development on biotechnology.
Available visa routes:
* Costs are estimates based on 2026 rates. Actual costs may vary.
Ask AI about visa requirementsSponsor licenses change frequently. Always verify on the official GOV.UK register before applying.